I am deeply passionate about advancing clinical research and leveraging innovative imaging technologies to enhance therapeutic development. With extensive experience in immuno-oncology, biomarker strategies, and investigator-initiated studies, I specialize in bridging the gap between cutting-edge science and real-world clinical applications.Currently, I focus on enabling the use of CD8 ImmunoPET imaging, a powerful tool for visualizing and quantifying CD8+ T-cell dynamics in vivo. By collaborating with leading pharmaceutical and biotech companies, as well as academic institutions, I help integrate this technology into early-phase trials, expediting the discovery of novel therapies and improving patient outcomes.Highlights of my expertise include:-Partnering with clinical and translational teams to optimize trial design using imaging biomarkers.-Identifying opportunities to align imaging solutions with therapeutic objectives.-Building strong collaborations with key stakeholders, including clinical investigators, regulatory teams, and technology innovators.Driven by curiosity and collaboration, I aim to contribute to groundbreaking advancements that reshape how we approach immunotherapy and precision medicine.Let’s connect if you're exploring innovative imaging solutions for your pipeline or looking to accelerate clinical trial insights!